The Interplay of Circulating Tumor DNA and Chromatin Modification, Therapeutic Resistance, and Metastasis

Molecular Cancer - United Kingdom
doi 10.1186/s12943-019-0989-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Circulating Tumor Cells: Silent Predictors of Metastasis

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Tumor Dormancy: Potential Therapeutic Target in Tumor Recurrence and Metastasis Prevention

Experimental Hematology and Oncology
Cancer ResearchOncologyHematology
2013English

Biophysical Technologies for Understanding Circulating Tumor Cell Biology and Metastasis

Translational Lung Cancer Research
Oncology
2017English

Monitoring Treatment Efficacy and Resistance in Breast Cancer Patients via Circulating Tumor DNA Genomic Profiling

Molecular genetics & genomic medicine
GeneticsMolecular Biology
2019English

Cornering Metastases: Therapeutic Targeting of Circulating Tumor Cells and Stem Cells

Frontiers in Oncology
Cancer ResearchOncology
2012English

Circulating Cell-Free DNA and Circulating Tumor Cells, the “Liquid Biopsies” in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2017English

Circulating Tumor DNA to Monitor Treatment Response and Detect Acquired Resistance in Patients With Metastatic Melanoma

Oncotarget
Oncology
2015English

Circulating and Disseminated Tumor Cells: Diagnostic Tools and Therapeutic Targets in Motion

Oncotarget
Oncology
2016English

The Interplay Between DNA Topoisomerase 2α Post-Translational Modifications and Drug Resistance

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy